Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 107INDUSTRY 11OTHER_GOV 4UNKNOWN 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Stomach Neoplasms 1Colorectal Neoplasms 1

Interventions

S 1 (combination) 16Paclitaxel 11Oxaliplatin 10Capecitabine 10Cisplatin 7Irinotecan 6titanium silicide 5sintilimab 4nimotuzumab 4nedaplatin 4TP protocol 3HMPL-013 3Fluorouracil 3Bevacizumab 3130-nm albumin-bound paclitaxel 3toripalimab 2raltitrexed 2Trastuzumab 2Tegafur 2Surgical Procedures, Operative 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Adjuvant 2Radiosurgery 2Radiation 2Neoadjuvant Therapy 2Leucovorin 2Esophagectomy 2Docetaxel 2Chemotherapy, Adjuvant 2Albumin-Bound Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
UNKNOWN × toripalimab × Gastrointestinal × Clear all
NCT04119622 2022-03-11

Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer

ChineseAMS

Phase 2 Unknown
30 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03927898 2019-04-25

Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis

ChineseAMS

Phase 2 Unknown
40 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡